TNNI3 and cardiovascular disorder: A different ARIC substudy [31], including 8121 participants free of cardiovascular disease at baseline and followed for 15 years, reported the association of elevated hs-cTnI levels (≥3.8 ng/L) with incident coronary heart disease, hospitalization for HF and global CVD using a risk factor adjusted model.